GlassScriptPhysician profile
Brett A Levine
NPI 1063413110
$45,823.79
in general payments reported to CMS, 2019-2025
32 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $40K · 2021: $820 · 2022: $879 · 2023: $704 · 2024: $766 · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513 · Consulting Fee: $50.00 · Travel and Lodging: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,512.52 |
| Consulting Fee | $50.00 |
| Travel and Lodging | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $39,546.96 | 2020 | |
| Stryker Corporation | $1,803.90 | 2019-2025 | Xpress Loprofile, Latera, Scopis Ent |
| Glaxosmithkline, LLC. | $850.19 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $821.89 | 2019-2025 | Dupixent |
| Genzyme Corporation | $553.13 | 2019-2025 | |
| Medical Device Business Services, INC. | $487.16 | 2019 | |
| Acclarent, INC | $333.63 | 2019-2021 | |
| Optinose US, INC. | $241.05 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $192.50 | 2023-2025 | Persona |
| Aerin Medical INC. | $138.10 | 2019-2023 | |
| Bard Access Systems, INC. | $93.60 | 2019 | |
| Merz Pharmaceuticals, LLC | $72.06 | 2021-2022 | |
| Smith+Nephew, INC. | $69.68 | 2019-2025 | Tula, Sinu-Foam, Ent Sinus |
| Baxter Healthcare | $66.33 | 2022-2025 | Perclot |
| Hikma Pharmaceuticals USA | $55.20 | 2024-2025 | Ryaltris |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $53.04 | 2023-2024 | Blastx, Xperience, Surgx |
| Amgen INC. | $48.43 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $45.44 | 2021-2023 | |
| Intersect Ent, INC. | $40.89 | 2019-2020 | |
| Cook Medical LLC | $39.92 | 2019-2023 | Biodesign |
| Agiliti Surgical, INC. | $33.94 | 2019 | |
| Medline Industries LP | $33.47 | 2020 | |
| Inspire Medical Systems, INC. | $32.50 | 2025 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $28.85 | 2025 | Neffy |
| Lilly USA, LLC | $23.20 | 2025 | Zepbound |
| Acera Surgical, INC. | $21.13 | 2021 | |
| Xoran Technologies LLC | $20.17 | 2020 | |
| Medtronic, INC. | $18.24 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.77 | 2019 | |
| Karl Storz Endoscopy-America | $15.31 | 2019 | |
| Tactile Systems Technology INC | $14.17 | 2020 | |
| Ethicon US, LLC | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.